logo
Quick Facts
  

Covis Announces Commencement Of $13.75/shr Tender Offer To Acquire AMAG - Quick Facts

By RTTNews Staff Writer   ✉   | Published:

Covis Group S.à r.l. announced the commencement of a cash tender offer to purchase all of the outstanding shares of common stock of AMAG Pharmaceuticals, Inc. (AMAG). The deal has a total enterprise value of approximately $647 million, including net debt. The tender offer will expire on November 12, 2020.

Covis is a global specialty pharmaceutical company that markets therapeutic solutions for patients with life-threatening conditions and chronic illnesses. It is headquartered in Luxembourg with operations in Zug, Switzerland.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Schlumberger Q4 Profit Surges 61%, Results Top Estimates
Oilfield services company Schlumberger Ltd. reported Friday a profit for the fourth quarter that surged 61 percent from last year, reflecting 13 percent higher revenues amid growth across all segments and regions. Both adjusted earnings per share and quarterly revenues topped analysts' estimates.
Twitter's Blue Subscribers Can Keep NFT Profile Pictures
Twitter Inc. has launched a new feature to allow some users of its Blue subscriber service to keep non-fungible tokens or NFTs as their profile pictures. Twitter Blue is now available in the US, Canada, Australia, and New Zealand. NFT is a crypto token, which is non-fungible, meaning that it can neither be transferred like money nor replaced with something else.
Frozen Food Development Recalls Lidl Branded Chopped Spinach
Frozen Food Development is recalling specific lots of Lidl branded 12-ounce packages of Frozen Chopped Spinach citing the potential to be contaminated with Listeria monocytogenes, the U.S. Food and Drug Administration said. The product comes in 12-ounce poly bags, and items included in the recall are marked with lot # R17742 or R17963 on the back of the poly bag with a best by date of 09/10/23.
Latest Updates on COVID-19
Read More
COVID-19: Drugs in Development
Follow RTT
Copyright © 2022 RTTNews. All rights reserved. By using this site, you agree to the Terms of Service. About Us   |   Contact Us   |   Privacy   |   Sitemap